What percentage of Lyrica (pregabalin) is removed through renal excretion in a patient with severe impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pregabalin Elimination in Dialysis Patients with Severe Renal Impairment

In a patient with GFR of 8 requiring dialysis, approximately 90% of a single 50mg pregabalin dose would be removed from renal excretion, necessitating significant dose adjustment and careful timing around dialysis sessions. 1

Pregabalin Pharmacokinetics in Severe Renal Impairment

  • Pregabalin is primarily eliminated through renal excretion with approximately 90% of the drug excreted unchanged in the urine 1
  • Total and renal pregabalin clearance are directly proportional to creatinine clearance (approximately 56-58% proportional to CrCl) 1
  • In patients with severe renal impairment (GFR <15 mL/min), pregabalin clearance is dramatically reduced, leading to drug accumulation and increased risk of toxicity 1, 2

Hemodialysis Effects on Pregabalin

  • Pregabalin is highly dialyzable with approximately 50% removed during a standard 4-hour hemodialysis session 3
  • Hemodialysis clearance of pregabalin has been measured at 88.8 mL/min in case reports 4
  • The drug's properties that make it amenable to removal by hemodialysis include:
    • Low molecular weight (159.23 Da)
    • Relatively low volume of distribution (0.5 L/kg)
    • Lack of plasma protein binding 4

Dosing Recommendations for Dialysis Patients

  • For patients with CrCl <15 mL/min (including those on hemodialysis), the pregabalin dose should be significantly reduced compared to patients with normal renal function 1
  • Daily doses should be reduced by approximately 50% for each 50% decrease in CrCl below 60 mL/min 1
  • Supplemental doses may be required after each hemodialysis session to maintain therapeutic levels 1
  • Medication administration should be scheduled after hemodialysis to avoid premature removal of the drug 5

Risks of Inappropriate Dosing in Renal Failure

  • Pregabalin toxicity in renal failure can manifest as:
    • Myoclonus
    • Encephalopathy
    • Reduced consciousness
    • Confusion
    • Agitation 3, 6, 4
  • Abrupt discontinuation of pregabalin in patients with renal impairment can lead to withdrawal symptoms including seizures 7

Clinical Implications

  • For a patient with GFR of 8 requiring dialysis, a single 50mg dose would have significantly altered pharmacokinetics:
    • Elimination half-life would be substantially prolonged (normal t1/2 is 6.3 hours) 2
    • Area under the curve (AUC) would be markedly increased 1
    • Approximately 50% of the drug would be removed during a standard hemodialysis session 3
  • Regular medication reconciliation at each transition of care is essential to prevent inappropriate dosing in dialysis patients 5

Management of Pregabalin Toxicity

  • There is no specific antidote for pregabalin overdose 3
  • Hemodialysis is an effective method for removing pregabalin in cases of toxicity 3, 4
  • Supportive care with monitoring of vital signs and clinical status is recommended 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.